Bugger off on the FINRA numbers. Thumbs up to the PR, the suits are in the room with Leo and he has to choose the best match(es) for each drug candidate. The mass production is being lined up with more deals to follow the closer drugs approach FDA approval.

Going to love the pain of those who have been nickel and diming during this waiting period when the big gaps happen.

Thank you Leo for keeping us bringing us up to date. Looking forward to the next significant announcement.